CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Clinical trial NCT04269213 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04269213
Sponsor: Roswell Park Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia With Myelodysplasia-Related Changes Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia

Start date: 2021-07-29
Primary completion: 2025-04-10
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.